MRI for Molecular ImagingApplications: Overview, Perspectives, and Challenges

Genomic and Personalized Medicine, Two-Vol Set

Volumn , Issue , 2009, Pages 512-523

  Artemov, Dmitri ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884786275     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369420-1.00045-7     Document Type: Chapter

References (68)

1. Ahrens E.T., Flores R., Xu H., Morel P.A. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005, 23:983-987.
2. Aime S., Delli Castelli D., Fedeli F., Terreno E. A paramagnetic MRI-CEST agent responsive to lactate concentration. J Am Chem Soc 2002, 124:9364-9365.
3. Aime S., Delli Castelli D., Terreno E. Supramolecular adducts between poly-L-arginine and [TmIIIdotp]: A route tosensitivity-enhanced magnetic resonance imaging-chemical exchange saturation transfer agents. Angew Chem Int Ed Engl 2003, 42:4527-4529.
4. Anderson S.A., Rader R.K., Westlin W.F., Null C., Jackson D., Lanza G.M., Wickline S.A., Kotyk J.J. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000, 44:433-439.
5. Artemov, D., Mori, N., Ravi, R. and Bhujwalla, Z. (2002). MR molecular imaging of Her-2/Neu receptor with Gd based targeted contrast agent. International Society for Magnetic Resonance in Medicine, Honolulu.
6. Artemov D., Mori N., Ravi R., Bhujwalla Z.M. Magnetic resonance molecular imaging of the Her-2/neu receptor. Cancer Res 2003, 63:2723-2727.
7. Auricchio A., Zhou R., Wilson J.M., Glickson J.D. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc Natl Acad Sci USA 2001, 98:5205-5210.
8. Bhorade R., Weissleder R., Nakakoshi T., Moore A., Tung C.H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem 2000, 11:301-305.
9. Brown M.A. MRI: Basic principles and applications 2003, Wiley-Liss, Hoboken, NJ.
10. Brown T.R., Kincaid B.M., Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A 1982, 79:3523-3526.
11. Bulte J.W. Hot spot MRI emerges from the background. Nat Biotechnol 2005, 23:945-946.
12. Bulte J.W., Hoekstra Y., Kamman R.L., Magin R.L., Webb A.G., Briggs R.W., Go K.G., Hulstaert C.E., Miltenyi S., The T.H. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992, 25:148-157.
13. Bulte J.W., Duncan I.D., Frank J.A. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002, 22:899-907.
14. Bulte J.W., Arbab A.S., Douglas T., Frank J.A. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Meth Enzymol 2004, 386:275-299.
15. Cohen B., Dafni H., Meir G., Harmelin A., Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005, 7:109-117.
16. Corot C., Idee J.M., Hentsch A.M., Santus R., Mallet C., Goulas V., Bonnemain B., Meyer D. Structure-activityrelationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme. J Magn Reson Imaging 1998, 8:695-702.
17. Cunningham C.H., Arai T., Yang P.C., McConnell M.V., Pauly J.M., Conolly S.M. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005, 53:999-1005.
18. Dodd S.J., Williams M., Suhan J.P., Williams D.S., Koretsky A.P., Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999, 76:103-109.
19. Duyn J.H., van Gelderen P., Talagala L., Koretsky A., de Zwart J.A. Technological advances in MRI measurement of brain perfusion. J Magn Reson Imaging 2005, 22:751-753.
20. Evgenov N.V., Medarova Z., Dai G., Bonner-Weir S., Moore A. In vivo imaging of islet transplantation. Nat Med 2006, 12:144-148.
21. Gammon S.T., Villalobos V.M., Prior J.L., Sharma V., Piwnica-Worms D. Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: Chiral and sequence-specific effects on net cell uptake. Bioconjug Chem 2003, 14:368-376.
22. Gilad A.A., McMahon M.T., Walczak P., Winnard P.T.J., Raman V., Bulte J.W.M., van Zijl P.C.M. Artificial Reporter Gene Providing MRI Contrast In Vivo Based on Chemical Exchange 2006, International Society for Magnetic Resonance in Medicine, Seattle, WA.
23. Gillies R.J. NMR in Physiology and Biomedicine 1994, Academic Press, San Diego.
24. Golman K., Olsson L.E., Axelsson O., Mansson S., Karlsson M., Petersson J.S. Molecular imaging using hyperpolarized 13C. Br J Radiol 2003, 76(Spec No 2):S118-S127.
25. Golman K., Zandt R.I., Lerche M., Pehrson R., Ardenkjaer-Larsen J.H. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res 2006, 66(22):10855-10860.
26. Guivel-Scharen V., Sinnwell T., Wolff S.D., Balaban R.S. Detection of proton chemical exchange between metabolites and water in biological tissues. J Magn Reson 1998, 133:36-45.
27. Guttmacher A.E., Collins F.S. Genomic medicine - Aprimer. New Engl J Med 2002, 19:1512-1520.
28. Jung C.W., Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995, 13:661-674.
29. Karmarkar P.V., Kraitchman D.L., Izbudak I., Hofmann L.V., Amado L.C., Fritzges D., Young R., Pittenger M., Bulte J.W., Atalar E. MR-trackable intramyocardial injection catheter. Magn Reson Med 2004, 51:1163-1172.
30. Katz-Brull R., Lavin P.T., Lenkinski R.E. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002, 94:1197-1203.
31. Kauczor H., Surkau R., Roberts T. MRI using hyperpolarized noble gases. Eur Radiol 1998, 8:820-827.
32. Kircher M.F., Mahmood U., King R.S., Weissleder R., Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003, 63:8122-8125.
33. Koretsky A.P., Silva A.C. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004, 17:527-531.
34. Kurhanewicz J., Swanson M.G., Nelson S.J., Vigneron D.B. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002, 16:451-463.
35. Le Bihan D., Turner R., Moonen C.T., Pekar J. Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance. J Magn Reson Imaging 1991, 1:7-28.
36. Lee I.H., Bulte J.W., Schweinhardt P., Douglas T., Trifunovski A., Hofstetter C., Olson L., Spenger C. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol 2004, 187:509-516.
37. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000, 18:321-325.
38. McKnight T.R. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 2004, 31:605-617.
39. McMahon M.T., Gilad A.A., Zhou J., Sun P.Z., Bulte J.W., van Zijl P.C. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly- l-lysine and a starburst dendrimer. Magn Reson Med 2006, 55:836-847.
40. Monsky W.L., Fukumura D., Gohongi T., Ancukiewcz M., Weich H.A., Torchilin V.P., Yuan F., Jain R.K. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 1999, 59:4129-4135.
41. Moore A., Marecos E., Bogdanov A., Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000, 214:568-574.
42. Moore A., Medarova Z., Potthast A., Dai G. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 2004, 64:1821-1827.
43. Mori S., van Zijl P.C. Fiber tracking: principles and strategies - a technical review. NMR Biomed 2002, 15:468-480.
44. Nakahara T., Norberg S.M., Shalinsky D.R., Hu-Lowe D.D., McDonald D.M. Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors. Cancer Res 2006, 66:1434-1445.
45. Paganelli G., Grana C., Chinol M., Cremonesi M., De Cicco C., De Braud F., Robertson C., Zurrida S., Casadio C., Zoboli S., et al. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med 1999, 26:348-357.
46. Pautler R.G., Silva A.C., Koretsky A.P. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998, 40:740-748.
47. Prantner A.M., Sharma V., Garbow J.R., Piwnica-Worms D. Synthesis and characterization of a Gd-DOTA-D-permeation peptide for magnetic resonance relaxation enhancement of intracellular targets. Mol Imaging 2003, 2:333-341.
48. Rome C., Couillaud F., Moonen C.T. Gene expression and gene therapy imaging. Eur Radiol 2007, 17:305-319.
49. Seppenwoolde J.H., Viergever M.A., Bakker C.J. Passive tracking exploiting local signal conservation: The white marker phenomenon. Magn Reson Med 2003, 50:784-790.
50. Shapiro E.M., Skrtic S., Sharer K., Hill J.M., Dunbar C.E., Koretsky A.P. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 2004, 101:10901-10906.
51. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998, 4:623-626.
52. Slichter C.P. Principles of Magnetic Resonance 1990, Springer-Verlag, Berlin.
53. Snoussi K., Bulte J.W., Gueron M., Van Zijl P.C. Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med 2003, 49:998-1005.
54. Uzgiris E.E., Cline H., Moasser B., Grimmond B., Amaratunga M., Smith J.F., Goddard G. Conformation and structure of polymeric contrast agents for medical imaging. Biomacromolecules 2004, 5:54-61.
55. Wadghiri Y.Z., Blind J.A., Duan X., Moreno C., Yu X., Joyner A.L., Turnbull D.H. Manganese-enhanced magnetic resonance imaging (MEMRI) of mouse brain development. NMR Biomed 2004, 17:613-619.
56. Walczak P., Kedziorek D.A., Gilad A.A., Lin S., Bulte J.W. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005, 54:769-774.
57. Walter G.A., Cahill K.S., Huard J., Feng H., Douglas T., Sweeney H.L., Bulte J.W. Noninvasive monitoring of stem cell transfer for muscle disorders. Magn Reson Med 2004, 51:273-277.
58. Weissleder R., Lee A.S., Fischman A.J., Reimer P., Shen T., Wilkinson R., Callahan R.J., Brady T.J. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging. Radiology 1991, 181:245-249.
59. Weissleder R., Cheng H.C., Bogdanova A., Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997, 7:258-263.
60. Weissleder R., Moore A., Mahmood U., Bhorade R., Benveniste H., Chiocca E.A., Basilion J.P. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-355.
61. Winter P.M., Caruthers S.D., Kassner A., Harris T.D., Chinen L.K., Allen J.S., Lacy E.K., Zhang H., Robertson J.D., Wickline S.A., et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003, 63:5838-5843.
62. Woods M., Woessner D.E., Sherry A.D. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006, 35:500-511.
63. Wu A.M., Senter P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 2005, 23:1137-1146.
64. Zhang S., Winter P., Wu K., Sherry A.D. A novel europium(III)-based MRI contrast agent. J Am Chem Soc 2001, 123:1517-1518.
65. Zhao M., Beauregard D.A., Loizou L., Davletov B., Brindle K.M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001, 7:1241-1244.
66. Zhou J., Lal B., Wilson D.A., Laterra J., van Zijl P.C. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 2003, 50:1120-1126.
67. Zhou J., Payen J.F., Wilson D.A., Traystman R.J., van Zijl P.C. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003, 9:1085-1090.
68. Zhu W., Okollie B., Bhujwalla Z.M., Artemov D. Controlled Internalization and Recycling of Her-2/neu by Cross-Linking with an Avidin/Streptavidin-Biotin System for MR Enhancement 2006, International Society for Magnetic Resonance in Medicine, Seattle, WA.